SmithKline Avandia Recommended Only For Combination Use By CPMP
Executive Summary
SmithKline Beecham's thiazolidinedione antidiabetic Avandia is in the final stages of EU approval following a positive recommendation by the Committee for Proprietary Medicinal Products March 16.
You may also be interested in...
SmithKline's Avandia EU Monotherapy Indication Anticipated After 2003
A monotherapy indication for SmithKline Beecham's antidiabetic Avandia is not expected in Europe before 2003, the company said at a launch briefing July 24.
SmithKline's Avandia EU Monotherapy Indication Anticipated After 2003
A monotherapy indication for SmithKline Beecham's antidiabetic Avandia is not expected in Europe before 2003, the company said at a launch briefing July 24.
Internet privacy
Federal Trade Commission recommends that Congress enact legislation that "would set forth a basic level of privacy protection for consumer-oriented commercial websites" in a May 22 report. Legislation should require sites to provide "clear and conspicuous notice" of their information collection practices, to offer consumers choices as to how their personal identifying information is used, to offer consumers "reasonable access" to the information a site has collected about them and to take "reasonable steps" to protect the security of the information. The commission based its recommendation on a survey of commercial sites' information practices, which found only 20% of 335 sites sampled randomly implement all four information practice principles and that 42% of the 91 "most popular" groups of sites do. Among the randomly selected sites were several that offer online prescription filling, including Merck-Medco.com, More.com and Costco.com